Improving outcomes for older women with gynaecological malignancies.
The incidence of most gynaecological malignancies rises significantly with increasing age. With an ageing population, the proportion of women over the age of 65 with cancer is expected to rise substantially over the next decade. Unfortunately, survival outcomes are much poorer in older patients and evidence suggests that older women with gynaecological cancers are less likely to receive current standard of care treatment options. Despite this, older women are under-represented in practice changing clinical studies. The evidence for efficacy and tolerability is therefore extrapolated from a younger; often more fit population and applied to in every day clinical practice to older patients with co-morbidities. There has been significant progress in the development of geriatric assessment in oncology to predict treatment outcomes and tolerability however there is still no clear evidence that undertaking a geriatric assessment improves patient outcomes. Clinical trials focusing on treating older patients are urgently required. In this review, we discuss the evidence for treatment of gynaecological cancers as well as methods of assessing older patients for therapy. Potential biomarkers of ageing are also summarised.
Gynaecology Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London SW3 6JJ, United Kingdom.
Lucy
L
Dumas
Breast Unit, Royal Marsden NHS Foundation Trust, Downs Road, Sutton SM2 5PT, United Kingdom.
Alistair
A
Ring
Gynaecology Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London SW3 6JJ, United Kingdom.
John
J
Butler
Department of Ageing and Health, 9th Floor North Wing, St Thomas' Hospital, Guys & St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, United Kingdom; Division of Health and Social Care Research, King's College London, Capital House, 42 Weston Street, London SE1 3QD, United Kingdom.
Tania
T
Kalsi
Department of Ageing and Health, 9th Floor North Wing, St Thomas' Hospital, Guys & St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, United Kingdom; Division of Health and Social Care Research, King's College London, Capital House, 42 Weston Street, London SE1 3QD, United Kingdom.
Danielle
D
Harari
Gynaecology Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: susana.banerjee@rmh.nhs.uk.
Susana
S
Banerjee
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001918:Brachytherapy / Q000379:methods*; D017024:Chemotherapy, Adjuvant; D019468:Disease Management; D016889:Endometrial Neoplasms / Q000628:therapy*; D005260:Female; D016330:Frail Elderly; D015577:Geriatric Assessment; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D010051:Ovarian Neoplasms / Q000628:therapy*; D010052:Ovariectomy; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000628:therapy*
Cervix; Elderly; Endometrial; Older; Outcomes; Ovarian; Therapy
J Ovarian Res. 2013 Jun 28;6(1):42
23809664
J Clin Oncol. 2002 Jan 15;20(2):494-502
11786579
Br J Cancer. 2010 Mar 16;102(6):947-51
20197770
Clin Cancer Res. 2015 Oct 1;21(19):4257-61
26187614
Eur J Cancer. 2013 Dec;49(18):3831-8
24007819
J Intern Med. 2013 Jul;274(1):77-85
23414490
Eur J Cancer. 2014 Mar;50(4):862-3
24418723
J Geriatr Oncol. 2013 Jul;4(3):235-41
24070461
J Clin Endocrinol Metab. 2003 May;88(5):2019-25
12727948
Eur J Cancer. 2015 Oct;51(15):2191-2205
26421822
Ann Oncol. 2007 Feb;18(2):282-7
17082513
J Natl Cancer Inst. 2012 Aug 8;104(15):1133-63
22851269
J Clin Oncol. 2013 Oct 10;31(29):3711-8
24019549
Gynecol Oncol. 2012 Oct;127(1):75-82
22750127
Lancet. 2015 Jul 18;386(9990):249-57
26002111
J Clin Oncol. 2012 Jul 20;30(21):2654-63
22711857
Lancet. 2010 Mar 6;375(9717):816-23
20206777
Ann Oncol. 2012 Aug;23(8):2166-2172
22250183
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11299-304
18695223
Acta Oncol. 2012 Apr;51(4):441-53
22313338
N Engl J Med. 1999 Dec 30;341(27):2061-7
10615079
Cancer. 2012 Jul 15;118(14):3618-26
22038773
Int J Gynecol Cancer. 2016 Feb;26(2):282-9
26745698
Br J Cancer. 2006 Nov 20;95(10):1314-20
17088903
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):242-8
15031308
Aging (Albany NY). 2015 Dec;7(12):1066-76
26638179
J Geriatr Oncol. 2014 Apr;5(2):204-18
24495695
Clin Cancer Res. 2006 Oct 1;12(19):5720-5
17020976
Gynecol Oncol. 2015 Jun;137(3):401-5
25839911
N Engl J Med. 2010 Sep 2;363(10):943-53
20818904
Br J Cancer. 2015 Apr 28;112(9):1435-44
25871332
J Clin Oncol. 2014 Aug 20;32(24):2595-603
25071125
Ann Oncol. 2013 Nov;24(11):2808-13
24061628
Epidemiology. 2006 Mar;17(2):190-4
16477260
Eur J Cancer. 2009 Apr;45(6):1006-16
19121578
Crit Rev Oncol Hematol. 2008 Feb;65(2):156-63
18082416
J Natl Cancer Inst. 1997 Dec 17;89(24):1874-81
9414175
Gynecol Oncol. 2007 Nov;107(2):339-43
17707075
Obstet Gynecol. 2015 Jun;125(6):1345-1352
26000505
Am J Obstet Gynecol. 2004 May;190(5):1398-400
15167848
J Am Geriatr Soc. 1999 Apr;47(4):389-95
10203111
Crit Rev Oncol Hematol. 2005 Sep;55(3):241-52
16084735
Gynecol Oncol. 2015 Dec;139(3):401-6
26432038
Ann Oncol. 2015 Feb;26(2):288-300
24936581
Crit Rev Oncol Hematol. 2008 Jun;66(3):229-36
18243011
Radiother Oncol. 2009 May;91(2):197-201
18954913
Cancer. 1994 Jan 15;73(2):377-83
8293403
J Clin Oncol. 2016 May 1;34(13):1476-83
26884557
Br J Cancer. 2011 Nov 22;105(11):1795-803
22033277
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S898-904
26014156
N Engl J Med. 2011 Dec 29;365(26):2473-83
22204724
N Engl J Med. 2011 Dec 29;365(26):2484-96
22204725
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD006211
21735403
J Clin Oncol. 2015 Jan 20;33(3):244-50
25366685
Crit Rev Oncol Hematol. 2007 May;62(2):164-71
17169569
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2603-6
25159293
Am J Epidemiol. 2007 Jan 1;165(1):14-21
17043079
Gynecol Oncol. 2013 Sep;130(3):493-8
23747291
Cancer. 2012 Jul 1;118(13):3377-86
22072065
Gynecol Oncol. 2008 Oct;111(1):35-40
18707756
Gynecol Oncol. 2006 Jun;101(3):470-5
16413048
Crit Rev Oncol Hematol. 2011 Sep;79(3):302-7
20888781
Lancet. 2000 Apr 22;355(9213):1404-11
10791524
Ann Oncol. 2011 Nov;22(11):2417-2423
21402619
Lancet. 2011 Jan 8;377(9760):127-38
21183212
J Clin Oncol. 2011 Sep 20;29(27):3636-42
21709194
Gynecol Oncol. 2002 Jan;84(1):36-42
11748973
Gynecol Oncol. 2011 Jan;120(1):23-8
20933255
Lancet. 1993 Oct 23;342(8878):1032-6
8105269
Lancet Oncol. 2014 Apr;15(4):396-405
24582486
PLoS One. 2013 Dec 04;8(12):e81858
24324725
Ann Oncol. 2005 Nov;16(11):1795-800
16093275
J Clin Oncol. 2012 Jun 10;30(17):2039-45
22529265
Cancer. 2005 Jan 1;103(1):85-91
15540239
Am J Clin Oncol. 2012 Aug;35(4):322-8
21422992
J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):724-30
18693227
Ann Oncol. 2007 Feb;18(2):256-62
17082510
Gynecol Oncol. 2008 Apr;109(1):33-8
18261784
Lancet Oncol. 2014 Jul;15(8):852-61
24882434
J Clin Oncol. 2011 Sep 1;29(25):3457-65
21810685
J Clin Oncol. 2004 Nov 15;22(22):4626-31
15542812
J Clin Oncol. 2004 May 15;22(10):1807-14
15143073
J Cancer Res Clin Oncol. 2004 Jul;130(7):411-6
15160288
Aging Cell. 2005 Dec;4(6):287-90
16300480
J Clin Oncol. 2015 Nov 10;33(32):3826-33
26195697
Obstet Gynecol. 2015 Dec;126(6):1198-1206
26551187